The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initial safety results from a randomized, phase II study of high-risk colorectal cancer patients (stage IIIC) treated with either regorafenib or standard of care (no treatment) after adjuvant FOLFOX.
 
Thomas H. Cartwright
Consulting or Advisory Role - Alexion Pharmaceuticals; American Regent; Bayer; BTG; Celgene; Genentech; HERON; Lilly; Seagen; Taiho Pharmaceutical
Speakers' Bureau - Amgen; Astellas Medivation; AstraZeneca; Celgene; Incyte; Janssen Oncology; Taiho Pharmaceutical
Research Funding - Bayer
Expert Testimony - BTG
 
Thu-Cuc Nguyen
No Relationships to Disclose
 
Allen Lee Cohn
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Merrimack; Merrimack; Roche; Roche
Speakers' Bureau - Merrimack; Merrimack
 
Donald A. Richards
Consulting or Advisory Role - Boehringer Ingelheim; Insys Therapeutics; IntegraGen; Lilly; Merrimack; Pharmacyclics
Speakers' Bureau - Celgene